These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9674970

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit.
    Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ.
    Nephrol Dial Transplant; 2003 Mar; 18(3):543-51. PubMed ID: 12584277
    [Abstract] [Full Text] [Related]

  • 25. Assessment of Digoxin-Specific Fab Fragment Dosages in Digoxin Poisoning.
    Nordt SP, Clark RF, Machado C, Cantrell FL.
    Am J Ther; 2016 Mar; 23(1):e63-7. PubMed ID: 25379735
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR, Robert S.
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [Abstract] [Full Text] [Related]

  • 29. Clinical and pharmacokinetic profiles of digoxin immune Fab in four patients with renal impairment.
    Allen NM, Dunham GD, Sailstad JM, Findlay JW.
    DICP; 1991 Dec; 25(12):1315-20. PubMed ID: 1815424
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Localization of the renal excretion of the tritiated digoxin.
    Doherty JE, Ferrell CB, Towbin EJ.
    Am J Med Sci; 1969 Sep; 258(3):181-9. PubMed ID: 5824861
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Digoxin-Specific Antibody Fragment Dosing: A Case Series.
    Chhabra N, Valento M, Bryant SM, Aks SE.
    Am J Ther; 2016 Sep; 23(6):e1597-e1601. PubMed ID: 26057142
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.
    Butler VP, Schmidt DH, Smith TW, Haber E, Raynor BD, Demartini P.
    J Clin Invest; 1977 Feb; 59(2):345-59. PubMed ID: 299860
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion.
    Saitoh S, Scicli AG, Peterson E, Carretero OA.
    Hypertension; 1995 May; 25(5):1008-13. PubMed ID: 7737707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.